Compile Data Set for Download or QSAR
maximum 50k data
Found 239 Enz. Inhib. hit(s) with Target = 'Bromodomain-containing protein 4 [349-460]'
TargetBromodomain-containing protein 4 [349-460](Homo sapiens (Human))
Tensha Therapeutics

US Patent
LigandPNGBDBM223491(US10407441, Compound JQ6 | US10925881, Name (S)-JQ...)
Affinity DataIC50:  0.240nMAssay Description:The binding activity of lead compounds with the BRD4 site 2 was determined by Alpha-assay with a 12-point dose response curveMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBromodomain-containing protein 4 [349-460](Homo sapiens (Human))
Tensha Therapeutics

US Patent
LigandPNGBDBM576088(N-(1-(4-chlorobenzyl)-2- methyl-6-(6-methyl-7-oxo-...)
Affinity DataIC50:  0.400nMAssay Description:The assays of BRD4 (D1) and BRD4 (D2) were conducted in a 384-well polystyrene plate. The test compounds were first serially diluted in DMSO and the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBromodomain-containing protein 4 [349-460](Homo sapiens (Human))
Tensha Therapeutics

US Patent
LigandPNGBDBM223492(US10407441, Compound JQ8 | US10925881, Name (S)-JQ...)
Affinity DataIC50:  0.427nMAssay Description:The binding activity of lead compounds with the BRD4 site 2 was determined by Alpha-assay with a 12-point dose response curveMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBromodomain-containing protein 4 [349-460](Homo sapiens (Human))
Tensha Therapeutics

US Patent
LigandPNGBDBM576114(N-(3-(2,4-difluorobenzyl)-2- methyl-5-(6-methyl-7-...)
Affinity DataIC50:  0.5nMAssay Description:The assays of BRD4 (D1) and BRD4 (D2) were conducted in a 384-well polystyrene plate. The test compounds were first serially diluted in DMSO and the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBromodomain-containing protein 4 [349-460](Homo sapiens (Human))
Tensha Therapeutics

US Patent
LigandPNGBDBM576106(N-(5-(6-methyl-7-oxo-6,7- dihydro-1H-pyrrolo[2,3-c...)
Affinity DataIC50:  0.5nMAssay Description:The assays of BRD4 (D1) and BRD4 (D2) were conducted in a 384-well polystyrene plate. The test compounds were first serially diluted in DMSO and the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBromodomain-containing protein 4 [349-460](Homo sapiens (Human))
Tensha Therapeutics

US Patent
LigandPNGBDBM576107(N-(3-(2,4-difluorobenzyl)-5- (6-methyl-7-oxo-6,7-d...)
Affinity DataIC50:  0.5nMAssay Description:The assays of BRD4 (D1) and BRD4 (D2) were conducted in a 384-well polystyrene plate. The test compounds were first serially diluted in DMSO and the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBromodomain-containing protein 4 [349-460](Homo sapiens (Human))
Tensha Therapeutics

US Patent
LigandPNGBDBM223493(US10407441, Compound JQ13 | US10925881, Name (S)-J...)
Affinity DataIC50:  0.584nMAssay Description:The binding activity of lead compounds with the BRD4 site 2 was determined by Alpha-assay with a 12-point dose response curveMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBromodomain-containing protein 4 [349-460](Homo sapiens (Human))
Tensha Therapeutics

US Patent
LigandPNGBDBM576112(N-(3-(3,5-difluorobenzyl)-5- (6-methyl-7-oxo-6,7-d...)
Affinity DataIC50:  1.20nMAssay Description:The assays of BRD4 (D1) and BRD4 (D2) were conducted in a 384-well polystyrene plate. The test compounds were first serially diluted in DMSO and the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBromodomain-containing protein 4 [349-460](Homo sapiens (Human))
Tensha Therapeutics

US Patent
LigandPNGBDBM576047(4-(1-(3-chlorobenzyl)-2- methyl-1H-imidazo[4,5-b] ...)
Affinity DataIC50:  1.40nMAssay Description:The assays of BRD4 (D1) and BRD4 (D2) were conducted in a 384-well polystyrene plate. The test compounds were first serially diluted in DMSO and the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBromodomain-containing protein 4 [349-460](Homo sapiens (Human))
Tensha Therapeutics

US Patent
LigandPNGBDBM576064(6-methyl-4-(2-methyl-1-(4- (trifluoromethyl)benzyl...)
Affinity DataIC50:  1.60nMAssay Description:The assays of BRD4 (D1) and BRD4 (D2) were conducted in a 384-well polystyrene plate. The test compounds were first serially diluted in DMSO and the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBromodomain-containing protein 4 [349-460](Homo sapiens (Human))
Tensha Therapeutics

US Patent
LigandPNGBDBM576063(4-(1-(4-chlorobenzyl)-2-methyl- 1H-imidazo[4,5-b]p...)
Affinity DataIC50:  1.70nMAssay Description:The assays of BRD4 (D1) and BRD4 (D2) were conducted in a 384-well polystyrene plate. The test compounds were first serially diluted in DMSO and the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBromodomain-containing protein 4 [349-460](Homo sapiens (Human))
Tensha Therapeutics

US Patent
LigandPNGBDBM576066(4-(1-(1-(4-chlorophenyl)ethyl)- 2-methyl-1H-imidaz...)
Affinity DataIC50:  1.80nMAssay Description:The assays of BRD4 (D1) and BRD4 (D2) were conducted in a 384-well polystyrene plate. The test compounds were first serially diluted in DMSO and the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBromodomain-containing protein 4 [349-460](Homo sapiens (Human))
Tensha Therapeutics

US Patent
LigandPNGBDBM576085(Compound 38 (4-(1-(2,6-dichlorobenzyl)-2-methyl-1H...)
Affinity DataIC50:  2.20nMAssay Description:The assays of BRD4 (D1) and BRD4 (D2) were conducted in a 384-well polystyrene plate. The test compounds were first serially diluted in DMSO and the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBromodomain-containing protein 4 [349-460](Homo sapiens (Human))
Tensha Therapeutics

US Patent
LigandPNGBDBM576043(4-(1-(4-chlorobenzyl)-2-methyl- 1H-imidazo[4,5-b]p...)
Affinity DataIC50:  2.5nMAssay Description:The assays of BRD4 (D1) and BRD4 (D2) were conducted in a 384-well polystyrene plate. The test compounds were first serially diluted in DMSO and the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBromodomain-containing protein 4 [349-460](Homo sapiens (Human))
Tensha Therapeutics

US Patent
LigandPNGBDBM576065(4-(1-(4-methoxybenzyl)-2- methyl-1H-imidazo[4,5-b]...)
Affinity DataIC50:  2.5nMAssay Description:The assays of BRD4 (D1) and BRD4 (D2) were conducted in a 384-well polystyrene plate. The test compounds were first serially diluted in DMSO and the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBromodomain-containing protein 4 [349-460](Homo sapiens (Human))
Tensha Therapeutics

US Patent
LigandPNGBDBM576087(Compound 40 (4-(1-((4-chlorophenyl)sulfonyl)-1H-py...)
Affinity DataIC50:  2.5nMAssay Description:The assays of BRD4 (D1) and BRD4 (D2) were conducted in a 384-well polystyrene plate. The test compounds were first serially diluted in DMSO and the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBromodomain-containing protein 4 [349-460](Homo sapiens (Human))
Tensha Therapeutics

US Patent
LigandPNGBDBM576049(4-(1-benzyl-2-methyl-1H- imidazo[4,5-b]pyridin-6-y...)
Affinity DataIC50:  2.80nMAssay Description:The assays of BRD4 (D1) and BRD4 (D2) were conducted in a 384-well polystyrene plate. The test compounds were first serially diluted in DMSO and the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBromodomain-containing protein 4 [349-460](Homo sapiens (Human))
Tensha Therapeutics

US Patent
LigandPNGBDBM576083(Compound 36 (4-(1-(2,6-dichlorobenzyl)-1H-pyrrolo[...)
Affinity DataIC50:  2.90nMAssay Description:The assays of BRD4 (D1) and BRD4 (D2) were conducted in a 384-well polystyrene plate. The test compounds were first serially diluted in DMSO and the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBromodomain-containing protein 4 [349-460](Homo sapiens (Human))
Tensha Therapeutics

US Patent
LigandPNGBDBM576044(4-(1-(4-methoxybenzyl)-2- methyl-1H-imidazo[4,5-b]...)
Affinity DataIC50:  3nMAssay Description:The assays of BRD4 (D1) and BRD4 (D2) were conducted in a 384-well polystyrene plate. The test compounds were first serially diluted in DMSO and the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBromodomain-containing protein 4 [349-460](Homo sapiens (Human))
Tensha Therapeutics

US Patent
LigandPNGBDBM576045(6-methyl-4-(2-methyl-1-(4- methylthio)benzyl)-1H-i...)
Affinity DataIC50:  3.20nMAssay Description:The assays of BRD4 (D1) and BRD4 (D2) were conducted in a 384-well polystyrene plate. The test compounds were first serially diluted in DMSO and the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBromodomain-containing protein 4 [349-460](Homo sapiens (Human))
Tensha Therapeutics

US Patent
LigandPNGBDBM576046(6-methyl-4-(2-methyl-1-(4- (trifluoromethyl)benzyl...)
Affinity DataIC50:  4nMAssay Description:The assays of BRD4 (D1) and BRD4 (D2) were conducted in a 384-well polystyrene plate. The test compounds were first serially diluted in DMSO and the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBromodomain-containing protein 4 [349-460](Homo sapiens (Human))
Tensha Therapeutics

US Patent
LigandPNGBDBM552060(US11312726, Compound 31)
Affinity DataIC50:  5nMAssay Description:The experiment plate was a plate that contained a gradient concentration of the compound and a corresponding DMSO solution and was prepared with ECHO...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBromodomain-containing protein 4 [349-460](Homo sapiens (Human))
Tensha Therapeutics

US Patent
LigandPNGBDBM576082(Compound 35 (4-(3-(1-(2,6-dichloro-3-fluorophenyl)...)
Affinity DataIC50:  5.30nMAssay Description:The assays of BRD4 (D1) and BRD4 (D2) were conducted in a 384-well polystyrene plate. The test compounds were first serially diluted in DMSO and the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBromodomain-containing protein 4 [349-460](Homo sapiens (Human))
Tensha Therapeutics

US Patent
LigandPNGBDBM576051(6-methyl-4-(2-methyl-1H- imidazo[4,5-b]pyridin-6-y...)
Affinity DataIC50:  6nMAssay Description:The assays of BRD4 (D1) and BRD4 (D2) were conducted in a 384-well polystyrene plate. The test compounds were first serially diluted in DMSO and the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBromodomain-containing protein 4 [349-460](Homo sapiens (Human))
Tensha Therapeutics

US Patent
LigandPNGBDBM483491(US10925881, Name (S)-JQ35)
Affinity DataIC50:  6.13nMAssay Description:The binding activity of lead compounds with the BRD4 site 2 was determined by Alpha-assay with a 12-point dose response curveMore data for this Ligand-Target Pair
In DepthDetails US Patent
TargetBromodomain-containing protein 4 [349-460](Homo sapiens (Human))
Tensha Therapeutics

US Patent
LigandPNGBDBM552046(US11312726, Compound 17)
Affinity DataIC50:  7nMAssay Description:The experiment plate was a plate that contained a gradient concentration of the compound and a corresponding DMSO solution and was prepared with ECHO...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBromodomain-containing protein 4 [349-460](Homo sapiens (Human))
Tensha Therapeutics

US Patent
LigandPNGBDBM576086(Compound 39 (4-(1-(4-chlorobenzyl)-1H-pyrazolo[4,3...)
Affinity DataIC50:  7.90nMAssay Description:The assays of BRD4 (D1) and BRD4 (D2) were conducted in a 384-well polystyrene plate. The test compounds were first serially diluted in DMSO and the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBromodomain-containing protein 4 [349-460](Homo sapiens (Human))
Tensha Therapeutics

US Patent
LigandPNGBDBM552047(US11312726, Compound 18)
Affinity DataIC50:  8nMAssay Description:The experiment plate was a plate that contained a gradient concentration of the compound and a corresponding DMSO solution and was prepared with ECHO...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBromodomain-containing protein 4 [349-460](Homo sapiens (Human))
Tensha Therapeutics

US Patent
LigandPNGBDBM552043(US11312726, Compound 14)
Affinity DataIC50:  8nMAssay Description:The experiment plate was a plate that contained a gradient concentration of the compound and a corresponding DMSO solution and was prepared with ECHO...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBromodomain-containing protein 4 [349-460](Homo sapiens (Human))
Tensha Therapeutics

US Patent
LigandPNGBDBM552042(US11312726, Compound 13)
Affinity DataIC50:  8nMAssay Description:The experiment plate was a plate that contained a gradient concentration of the compound and a corresponding DMSO solution and was prepared with ECHO...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBromodomain-containing protein 4 [349-460](Homo sapiens (Human))
Tensha Therapeutics

US Patent
LigandPNGBDBM552048(US11312726, Compound 19)
Affinity DataIC50:  8nMAssay Description:The experiment plate was a plate that contained a gradient concentration of the compound and a corresponding DMSO solution and was prepared with ECHO...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBromodomain-containing protein 4 [349-460](Homo sapiens (Human))
Tensha Therapeutics

US Patent
LigandPNGBDBM552056(US11312726, Compound 27)
Affinity DataIC50:  9nMAssay Description:The experiment plate was a plate that contained a gradient concentration of the compound and a corresponding DMSO solution and was prepared with ECHO...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBromodomain-containing protein 4 [349-460](Homo sapiens (Human))
Tensha Therapeutics

US Patent
LigandPNGBDBM552059(US11312726, Compound 30)
Affinity DataIC50:  9nMAssay Description:The experiment plate was a plate that contained a gradient concentration of the compound and a corresponding DMSO solution and was prepared with ECHO...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBromodomain-containing protein 4 [349-460](Homo sapiens (Human))
Tensha Therapeutics

US Patent
LigandPNGBDBM552034(US11312726, Compound 5)
Affinity DataIC50:  9nMAssay Description:The experiment plate was a plate that contained a gradient concentration of the compound and a corresponding DMSO solution and was prepared with ECHO...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBromodomain-containing protein 4 [349-460](Homo sapiens (Human))
Tensha Therapeutics

US Patent
LigandPNGBDBM552051(US11312726, Compound 22)
Affinity DataIC50:  10nMAssay Description:The experiment plate was a plate that contained a gradient concentration of the compound and a corresponding DMSO solution and was prepared with ECHO...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBromodomain-containing protein 4 [349-460](Homo sapiens (Human))
Tensha Therapeutics

US Patent
LigandPNGBDBM552031(US11312726, Compound 2)
Affinity DataIC50:  10nMAssay Description:The experiment plate was a plate that contained a gradient concentration of the compound and a corresponding DMSO solution and was prepared with ECHO...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBromodomain-containing protein 4 [349-460](Homo sapiens (Human))
Tensha Therapeutics

US Patent
LigandPNGBDBM552061(US11312726, Compound 32)
Affinity DataIC50:  10nMAssay Description:The experiment plate was a plate that contained a gradient concentration of the compound and a corresponding DMSO solution and was prepared with ECHO...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBromodomain-containing protein 4 [349-460](Homo sapiens (Human))
Tensha Therapeutics

US Patent
LigandPNGBDBM552065(US11312726, Compound 36)
Affinity DataIC50:  10nMAssay Description:The experiment plate was a plate that contained a gradient concentration of the compound and a corresponding DMSO solution and was prepared with ECHO...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBromodomain-containing protein 4 [349-460](Homo sapiens (Human))
Tensha Therapeutics

US Patent
LigandPNGBDBM576050(4-(1,2-dimethyl-1H-imidazo [4,5-b]pyridin-6-yl)-6-...)
Affinity DataIC50:  10.8nMAssay Description:The assays of BRD4 (D1) and BRD4 (D2) were conducted in a 384-well polystyrene plate. The test compounds were first serially diluted in DMSO and the ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBromodomain-containing protein 4 [349-460](Homo sapiens (Human))
Tensha Therapeutics

US Patent
LigandPNGBDBM552030(US11312726, Compound 1)
Affinity DataIC50:  11nMAssay Description:The experiment plate was a plate that contained a gradient concentration of the compound and a corresponding DMSO solution and was prepared with ECHO...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBromodomain-containing protein 4 [349-460](Homo sapiens (Human))
Tensha Therapeutics

US Patent
LigandPNGBDBM552038(US11312726, Compound 9)
Affinity DataIC50:  11nMAssay Description:The experiment plate was a plate that contained a gradient concentration of the compound and a corresponding DMSO solution and was prepared with ECHO...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBromodomain-containing protein 4 [349-460](Homo sapiens (Human))
Tensha Therapeutics

US Patent
LigandPNGBDBM552037(US11312726, Compound 8)
Affinity DataIC50:  11nMAssay Description:The experiment plate was a plate that contained a gradient concentration of the compound and a corresponding DMSO solution and was prepared with ECHO...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBromodomain-containing protein 4 [349-460](Homo sapiens (Human))
Tensha Therapeutics

US Patent
LigandPNGBDBM552066(US11312726, Compound 37)
Affinity DataIC50:  11nMAssay Description:The experiment plate was a plate that contained a gradient concentration of the compound and a corresponding DMSO solution and was prepared with ECHO...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBromodomain-containing protein 4 [349-460](Homo sapiens (Human))
Tensha Therapeutics

US Patent
LigandPNGBDBM552049(US11312726, Compound 20)
Affinity DataIC50:  11nMAssay Description:The experiment plate was a plate that contained a gradient concentration of the compound and a corresponding DMSO solution and was prepared with ECHO...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBromodomain-containing protein 4 [349-460](Homo sapiens (Human))
Tensha Therapeutics

US Patent
LigandPNGBDBM552044(US11312726, Compound 15)
Affinity DataIC50:  11nMAssay Description:The experiment plate was a plate that contained a gradient concentration of the compound and a corresponding DMSO solution and was prepared with ECHO...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBromodomain-containing protein 4 [349-460](Homo sapiens (Human))
Tensha Therapeutics

US Patent
LigandPNGBDBM552063(US11312726, Compound 34)
Affinity DataIC50:  11nMAssay Description:The experiment plate was a plate that contained a gradient concentration of the compound and a corresponding DMSO solution and was prepared with ECHO...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBromodomain-containing protein 4 [349-460](Homo sapiens (Human))
Tensha Therapeutics

US Patent
LigandPNGBDBM552045(US11312726, Compound 16)
Affinity DataIC50:  12nMAssay Description:The experiment plate was a plate that contained a gradient concentration of the compound and a corresponding DMSO solution and was prepared with ECHO...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBromodomain-containing protein 4 [349-460](Homo sapiens (Human))
Tensha Therapeutics

US Patent
LigandPNGBDBM552064(US11312726, Compound 35)
Affinity DataIC50:  12nMAssay Description:The experiment plate was a plate that contained a gradient concentration of the compound and a corresponding DMSO solution and was prepared with ECHO...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBromodomain-containing protein 4 [349-460](Homo sapiens (Human))
Tensha Therapeutics

US Patent
LigandPNGBDBM552041(US11312726, Compound 12)
Affinity DataIC50:  12nMAssay Description:The experiment plate was a plate that contained a gradient concentration of the compound and a corresponding DMSO solution and was prepared with ECHO...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetBromodomain-containing protein 4 [349-460](Homo sapiens (Human))
Tensha Therapeutics

US Patent
LigandPNGBDBM552040(US11312726, Compound 11)
Affinity DataIC50:  14nMAssay Description:The experiment plate was a plate that contained a gradient concentration of the compound and a corresponding DMSO solution and was prepared with ECHO...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
Displayed 1 to 50 (of 239 total ) | Next | Last >>
Jump to: